Delfi Diagnostics
Kathryn Todd has a diverse work experience that includes positions at Delfi Diagnostics as the Director of IVD Development starting in 2022, Thermo Fisher Scientific where they served as Senior Manager, Systems Design Engineering from 2020 to 2022, and as a Senior Systems Engineer from August to October 2020. Prior to that, they worked at SRI International as an Associate Laboratory Director from 2018 to 2020 and as a Program Manager from 2010 to 2018. Kathryn began their career at Stanford University as a Postdoctoral Researcher from 2009 to 2010.
Kathryn Todd pursued their education at various prestigious institutions. From 1997 to 2001, they attended Caltech and obtained a Bachelor of Science degree in both Physics and Literature. Subsequently, they enrolled at Stanford University, where they spent eight years from 2001 to 2009, earning a Ph.D. in Physics.
This person is not in any teams
This person is not in any offices
Delfi Diagnostics
2 followers
Delfi Diagnostics is developing high-performing, accessible blood tests for early detection of cancer to help people live longer, healthier lives.